Literature DB >> 16985607

New Drug under Development for Stress and Urge Urinary Incontinence.

Hitoshi Masuda, Michael Chancellor.   

Abstract

Entities:  

Year:  2004        PMID： 16985607      PMCID： PMC1472841     

Source DB:  PubMed          Journal:  Rev Urol        ISSN： 1523-6161


× No keyword cloud information.
  2 in total

1.  Randomized, double-blind placebo- and tolterodine-controlled trial of the once-daily antimuscarinic agent solifenacin in patients with symptomatic overactive bladder.

Authors:  C R Chapple; T Rechberger; S Al-Shukri; P Meffan; K Everaert; M Huang; A Ridder
Journal:  BJU Int       Date:  2004-02       Impact factor: 5.588

2.  Duloxetine vs placebo in the treatment of stress urinary incontinence: a four-continent randomized clinical trial.

Authors:  R J Millard; K Moore; R Rencken; I Yalcin; R C Bump
Journal:  BJU Int       Date:  2004-02       Impact factor: 5.588
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.